Journal of Medical Economics, Volume 19, Issue 6 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 19, Issue 6 (2016)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Volume 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Diabetes

Article
Evaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective
Bradley H. Curtis, Sarah Curtis, Daniel R. Murphy, James C. Gahn, Sinem Perk, Harry J. Smolen, James Murray, Nana Numapau, Jeffrey S. Bonner, Rong Liu, Jennal Johnson & Leonard C. Glass
Pages: 549-556
Published online: 01 Feb 2016
AbstractforEvaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective | Full Text | References | PDF (718.2 KB) | Supplemental
  • 601 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada
Peter Quon, Hoa H. Le, Vincent Raymond, Mondher Mtibaa & Andriy Moshyk
Pages: 557-567
Published online: 03 Feb 2016
AbstractforClinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada | Full Text | References | PDF (954.1 KB)
  • 1064 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Article
Rates, factors, reasons, and economic impact associated with switching in rheumatoid arthritis patients newly initiated on biologic disease modifying anti-rheumatic drugs in an integrated healthcare system
Nazia Rashid, Antony T. Lin, Gustavus Aranda Jr, Kathy J. Lin, Valerie N. Guerrero, Anagha Nadkarni & Chad Patel
Pages: 568-575
Published online: 08 Feb 2016
AbstractforRates, factors, reasons, and economic impact associated with switching in rheumatoid arthritis patients newly initiated on biologic disease modifying anti-rheumatic drugs in an integrated healthcare system | Full Text | References | PDF (752.4 KB)
  • 1095 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Vaccines

Article
The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older
Juan Luis Lopez-Belmonte, Ramón Cisterna, Angel Gil de Miguel, Caroline Guilmet, Florence Bianic & Mathieu Uhart
Pages: 576-586
Published online: 02 Mar 2016
AbstractforThe use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older | Full Text | References | PDF (1.3 MB)
  • 1616 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
Estimating healthcare resource use associated with the treatment of metastatic melanoma in eight countries
Jan McKendrick, Merel Gijsen, Casey Quinn, Beth Barber & Zhongyun Zhao
Pages: 587-595
Published online: 10 Feb 2016
AbstractforEstimating healthcare resource use associated with the treatment of metastatic melanoma in eight countries | Full Text | References | PDF (797.9 KB)
  • 901 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Respiratory

Article
Co-calibrating quality-of-life scores from three pulmonary disorders: implications for comparative-effectiveness research
M. Rouse, J. Twiss & S. P. McKenna
Pages: 596-603
Published online: 19 Feb 2016
AbstractforCo-calibrating quality-of-life scores from three pulmonary disorders: implications for comparative-effectiveness research | Full Text | References | PDF (857.7 KB)
  • 467 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Article
Cost-effectiveness analysis of febuxostat in patients with gout in Spain
F. Perez-Ruiz, C. Díaz-Torné & D. Carcedo
Pages: 604-610
Published online: 22 Feb 2016
AbstractforCost-effectiveness analysis of febuxostat in patients with gout in Spain | Full Text | References | PDF (909.5 KB)
  • 1186 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost of skeletal complications from bone metastases in six European countries
J. Pereira, J.-J. Body, O. Gunther, H. Sleeboom, G. Hechmati, N. Maniadakis, E. Terpos, Y. P. Acklin, J. Finek & R von Moos
Pages: 611-618
Published online: 23 Feb 2016
AbstractforCost of skeletal complications from bone metastases in six European countries | Full Text | References | PDF (1.1 MB) | Supplemental
  • 929 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access
Article
A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada
C. Beauchemin, N. Letarte, K. Mathurin, L. Yelle & J. Lachaine
Pages: 619-629
Published online: 02 Mar 2016
AbstractforA global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada | Full Text | References | PDF (1.3 MB)
  • 2908 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access

Respiratory

Article
Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes
Ron Goeree, Julie Villeneuve, Jeff Goeree, John R. Penrod, Lucinda Orsini & Amir Abbas Tahami Monfared
Pages: 630-644
Published online: 01 Mar 2016
AbstractforEconomic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes | Full Text | References | PDF (2.1 MB) | Supplemental
  • 3541 Views
  • 44 CrossRef citations
  • 0Altmetric
Free Access

Pharmacology

Editorial
First monoclonal antibody biosimilars: tackling the challenge of substitution
François Bocquet & Pascal Paubel
Pages: 645-647
Published online: 29 Apr 2016
First Page PreviewforFirst monoclonal antibody biosimilars: tackling the challenge of substitution | Full Text | References | PDF (249 KB)
  • 2160 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles